Viruses
HIV
Treatment HIV - NIH 2024
Prevention & Treatment of OI - NIH 2024
Primary Care Guidance - HIVMA/IDSA 2024
SARS-CoV-2
COVID-19 Treatment - IDSA 2024
COVID-19 Serology - IDSA 2024
COVID-19 Molecular Diagnostics - IDSA 2023
COVID-19 - IDSA 2021
Hepatitis Viruses
Hepatitis B - Prevention and Treatment Reactivation - AGA 2025
Hepatitis C - AASLD/IDSA 2023
Hepatitis B Prevention, Diagnosis, Treatment (Update) - AASLD 2018
Hepatitis B Treatment - AASLD 2016
Other
Influenza - IDSA 2018
Bacteria
Bacteria
H. pylori - ACG 2024
C. difficile Fecal Microbiota Therapy - AGA 2024
C. difficile Treatment (focused update) - SHEA/IDSA 2021
C. difficile - ACG 2021
H. pylori Refractory - AGA 2021
C. difficile - SHEA/IDSA 2017
MRSA - IDSA 2011 (archived)
Spirochetes
Lyme Disease - AAN/ACR/IDSA 2020
Neuroborreliosis - AAN 2007 (retired)
Protozoa
Fungi
Yeasts
Cryptococcus - ECMM/ISHAM/ASM 2024
Candidiasis - IDSA 2015
Cryptococcus - IDSA 2010 (archived)
Molds
Aspergillosis - IDSA 2016
Endemic Mycoses
Histoplasmosis - IDSA 2025 (Update Part 1)
Coccidioidomycosis - IDSA 2016
Blastomycosis - IDSA 2008 (archived)
Histoplasmosis - IDSA 2007 (archived)
Sporotrichosis - IDSA 2007 (archived)
Mycobacteria
Tuberculosis
Treatment of Drug Susceptible and Drug Resistant Tb (Update) - ATS/CDC/ERS/IDSA 2024
Reduction Pulmonary Tb Transmission Community - NTCA 2024
Treatment Drug-Resistant Tb - ATS/CDC/ERS/IDSA 2019
Treatment Drug-Susceptible Tb - ATS/CDC/IDSA 2016
Diagnosis of Tb - ATS/CDC/IDSA 2016
Control of Tb - ATS/CDC/IDSA 2005
NTM
Pulmonary NTM Treatment - ATS/ERS/ESCMID/IDSA 2020
Pulmonary NTM Treatment - BTS 2017
Diagnosis & Treatment of NTM - ATS/IDSA 2007
Helminths
Neurocysticercosis - ASTMH/IDSA 2017